Uniquely Diverse Portfolio

Source: Based on Charles River and Inveresk LTM September 2004 financial results.

Pre-Clinical

• Leader in toxicology  

• Leader in specialty toxicology 
  • Infusion
  • Inhalation
  • Reproductive

• Leader in interventional & surgical services

• Leader in worldwide biosafety testing

• Leader in endotoxin detection

Clinical

• Phase I - IV coverage  

• Premier Phase I clinic

Research Models & Services

• Leading market position  

• Large number of widely used models
  • Disease models

• Leading service provider with broad capabilities

Previous slide

Next slide

Back to first slide

View graphic version